ALFA Finder| Revenue growth | 9% YoY growth in consolidated revenue. |
|---|---|
| Margins | EBITDA margins improved; PAT margins pressured by lower forex gains. |
| Management confidence | High; emphasizing strengthening platform for sustainable long-term value. |
Growth
Revenue grew 9% YoY; EBITDA margin expanded 220 bps to 16.6%. PAT fell 38% to ₹88 Cr due to lower forex gains.
Outlook
Capex for Q1 FY27 stood at ₹263 Cr. Focus remains on dossier development, registration investments, and expanding sales force.
Risks
Significant reduction in forex gains (₹7.5 Cr vs ₹73.1 Cr YoY) impacting bottom-line and EBIT margins.
Last quarter's promises, checked
Delivered
- Guided FY27 EBITDA margin 18-20% → delivered Q1 FY27 16.6% (= PARTIAL)
- Guided FY27 Revenue growth 10-15% → delivered Q1 FY27 9% (= MISS)
- Guided Agro-chemical growth → delivered +8% YoY (= BEAT)
Partly delivered
- Guided FY27 EBITDA margin 18-20% → delivered Q1 16.6% (= PARTIAL)
Missed
- Guided FY27 Revenue growth 10-15% → delivered Q1 FY27 9% (= MISS)
- Guided gross margins ~35% → delivered Q1 PAT margins pressured (= MISS)
Investor Presentation filed with NSE, NSE: SHARDACROP. Summary written with AI assistance from the document.
Sharda Cropchem Ltd: key numbers
- Share price
- ₹710.95
- Market cap
- ₹6,414 Cr
- Revenue (annual)
- ₹5,268 Cr
- Net profit (annual)
- ₹680.9 Cr
- P/E (TTM)
- 10.0×Sector 35.5×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 3.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharda Cropchem Ltd
All →Sharda Cropchem Earnings Call Transcript: Key Takeaways
Sharda Cropchem delivered double-digit revenue growth and margin expansion, led by strong performance in NAFTA and LATAM, despite European weather headwinds and volume de-growth.
- Call
- Guides 15% growth
Sharda Cropchem Results Update
Sharda Cropchem's Q2 FY27 revenue rose 13% to ₹1,052 crore; EBITDA grew 18% to ₹164 crore. H1 PAT declined 17% to ₹180 crore on lower forex gains.
Sharda Cropchem Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 1,052 Cr (+13%), EBITDA Rs 164 Cr (+18%), margin 15.6%, PAT Rs 92 Cr (+23%). H1 PAT down 17%.
Sharda Cropchem Q2 FY27 Results: Net Profit ₹91.7 Cr, Up 23.3% YoY
Sharda Cropchem Ltd reported revenue from operations of ₹1,052 Cr (+13.2% YoY) and net profit of ₹91.7 Cr (+23.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹91.7 Cr · +23.3% YoY
Sharda Cropchem Board Meeting Date
Sharada Cropchem scheduled a board meeting for 30 Oct 2026 to consider its H1 FY27 unaudited financial results. No financial figures or decisions are reported in this advance intimation.
Sharda Cropchem Other Announcement
Sharda Cropchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.